Acute Hospital Care Market Overview, Global Size, Industry Share, Competitive

Acute Hospital Care Market Analysis

The continually rising global acute hospital care market Size is estimated to see a dramatic increase in its size due to the ongoing Coronavirus crisis. At a time when the world is battling the COVID-19 pandemic, people suffering from myriads of chronic diseases are facing an acute shortage of hospital care. Most Covid-19 patients land up in intensive care units with severe respiratory distress. Hence, countries around the globe are working on a war footing to increase the number of intensive care, coronary care, neonatal intensive care, and cardiology units. 

Besides, the presence of large patient populations suffering from chronic diseases such as cancer & diabetes and increasing hospitalizations due to the prevailing trauma cases & severe road accidents accelerate the market demand exponentially.   Market Research Future (MRFR), states that the global acute hospital care market had generated significant value in 2018, which is estimated to appreciate further at a CAGR of 7.8% during the forecast period (2019–2024).

Additionally, rising R&D expenditures and aggressive growth strategies adopted by the top players, such as collaborations with caregiving organizations and new product launches, are contributing to the growth of the market. Moreover, factors such as the rising number of hospital and unmet medical needs are projected to boost the market growth over the anticipated period. Furthermore, increasing geriatric population, technological advances in the healthcare sector, and increasing cases of neurological disorders worldwide are expected to drive the growth of the market.

Conversely, the lack of adequate reimbursement policy and high costs involved in the deployments of acute hospital care centers are the key factors expected to impede the growth of the market. Also, the limited availability of facilities & equipment in underdeveloped countries such as Pakistan, Iran, and some of the countries in the African region may hamper market growth during the forecast period. Nevertheless, continual investments in rapidly developing countries such as India and China would support market growth throughout the assessment period.  

Acute Hospital Care Market -   Segmentations

The report is segmented into three dynamics;

By Medical Condition: Urgent Care, Emergency Care, Short-Term Stabilization, Trauma Care, Acute Care Surgery, and others.

By Services: Coronary Care, Intensive Care, Neonatal Intensive Care, and others.

By Regions: North America, Europe, APAC, and the Rest-of-the-World. 

Acute Hospital Care Market - Regional Analysis

North America leads the global acute hospital care market. The largest market share attributes to the well-developed technology led by the increasing government support for research & development, high health care spending, and increasing patient population. Furthermore, the presence of major companies and advanced healthcare facilities fuel the growth of the market in this region. Also, the increasing Corona positive cases are providing impetus to the growth of the regional market.

Besides, the rising prevalence of chronic diseases & disorders and rising road accidents and traumatic incidents foster the regional market growth. Considerable advancements in acute hospital care units and surging cases of hospitalizations act as a significant tailwind for the regional market growth.

Moreover, the well-proliferated healthcare sector and the increasing numbers of hospitals in the region impact the market growth positively. The North American acute hospital care market is projected to retain its leading position in the global market throughout the assessment period.

Europe stands second in the global acute hospital care market. The market is primarily driven by government support for research & development and availability of funds for research. Moreover, rising cases of hospitalization due to the prevalence of COVID 19 and myriads of chronic diseases in the region are likely to give a huge boost to the market growth. Germany and France, backed by the increasing investment in hospital infrastructure developments, contribute to the regional market growth exponentially. The European acute hospital care market is estimated to grow at a considerable CAGR during the review period.

The Asia Pacific acute hospital care market is growing rapidly. Factors such as the continually rising economy in the region that is increasing per capita healthcare expenses and advances in healthcare technology push the growth of the market. Besides, increasing demand for acute hospital care in countries like India and South Korea are likely to foster regional market growth. Furthermore, huge patient population and growing demand for quality devices in healthcare are the major factors estimated to increase the size of the market, leading to the use of advanced equipment. 

Acute Hospital Care Market – Competitive Landscape

Fiercely competitive, the acute hospital care market appears fragmented due to the presence of many well-established players. To gain a larger competitive share in the market, industry players incorporate strategic initiatives such as acquisitions & mergers, expansion, collaboration, and product & technology launch. They make substantial investments, which are majorly used to drive R&D and to expand their market presence.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/acute-hospital-care-market-4931

Acute Hospital Care Market Major Players 

Players active in the global acute hospital care market include Community Health Systems LLC (U.S.), Universal Health Services, Inc. (U.S.), HCA Holdings, Inc. (U.S.), Vanguard Health System Inc. (U.S.), Ardent Health Services (U.S.), Tenet Healthcare Corp. (U.S.), PruittHealth (U.S.), National HealthCare Corp.(U.S.), and Kindred Healthcare, Inc. (U.S.), and others.

Acute Hospital Care Industry/Innovation/Related News:

May 11, 2020 ---- Relief Therapeutics Holding SA (Switzerland), a leading biotechnology company, announced the filing of IND for phase 2/3 clinical trial of Inhaled RLF-100 targeting early COVID-19 lung injury. Also, RLF-100 is already undergoing clinical trials for the treatment of Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients on mechanical ventilation. 

About This Author

Sapana Joined: March 13th, 2019